0000950170-23-024313.txt : 20230526 0000950170-23-024313.hdr.sgml : 20230526 20230525191434 ACCESSION NUMBER: 0000950170-23-024313 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20230525 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20230526 DATE AS OF CHANGE: 20230525 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Singular Genomics Systems, Inc. CENTRAL INDEX KEY: 0001850906 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 812948451 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40443 FILM NUMBER: 23962571 BUSINESS ADDRESS: STREET 1: 3010 SCIENCE PARK ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 333-7830 MAIL ADDRESS: STREET 1: 3010 SCIENCE PARK ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 8-K 1 omic-20230525.htm 8-K 8-K
false000185090600018509062023-05-252023-05-25

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 25, 2023

 

 

Singular Genomics Systems, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware

001-40443

81-2948451

(State or other jurisdiction
of incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

3010 Science Park Road
San Diego, California 92121

 

(858) 333-7830
(Registrant’s address of principal executive offices

and telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of Each Class

 

Trading
Symbol(s)

 


Name of Each Exchange on Which Registered

Common Stock, par value $0.0001 per share

 

OMIC

 

Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

On May 25, 2023, Singular Genomics Systems, Inc. (the “Company”) held its 2023 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on the following proposals, which are described in more detail in the Company’s Definitive Proxy Statement on Schedule 14A that was filed with the U.S. Securities and Exchange Commission on April 13, 2023 (the “Proxy Statement”):
 

1.
To elect David Barker and Kim Kamdar as the Class II directors to serve until the 2026 annual meeting of stockholders or until their respective successors have been elected or appointed.
2.
To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023.

Only stockholders of record at the close of business on March 31, 2023 (the “Record Date”) were entitled to vote at the Annual Meeting. At the close of business on the Record Date, 72,388,932 shares of the Company's common stock were issued and outstanding, of which 55,661,943 shares of common stock were present at the Annual Meeting, either in attendance via the live webcast or represented by proxy, which total constituted a quorum of the issued and outstanding shares.
 

Each of the proposals voted on at the Annual Meeting was approved by the Company’s stockholders. The final voting results with respect to each of the proposals are set forth below.

Proposal 1: Election of Directors

Nominee

 

Votes For

 

 

 

Votes Withheld

 

 

 

Broker Non-Votes

 

David Barker

 

 

34,232,878

 

 

 

 

5,689,071

 

 

 

 

15,739,994

 

Kim Kamdar

 

 

35,825,042

 

 

 

 

4,096,907

 

 

 

 

15,739,994

 

 

Proposal 2: Ratification of Appointment of Independent Registered Accounting Firm

 

Votes For

 

 

 

Votes Against

 

 

 

Abstentions

 

 

55,594,144

 

 

 

 

49,256

 

 

 

 

18,543

 


 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Singular Genomics Systems, Inc.

 

 

 

 

Dated:

May 25, 2023

By:

/s/ Dalen Meeter

 

 

 

Dalen Meeter
Chief Financial Officer
Principal Financial Officer and Principal Accounting Officer

 

 

 EX-101.PRE 2 omic-20230525_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.LAB 3 omic-20230525_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Address, City or Town Entity Address, City or Town Soliciting Material Entity Ex Transition Period Entity Ex Transition Period Amendment Flag Amendment Flag Document Quarterly Report Document Quarterly Report Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Small Business Entity Small Business City Area Code City Area Code Document Period End Date Document Period End Date Entity Address, Postal Zip Code Entity Address, Postal Zip Code Document Fiscal Period Focus Document Fiscal Period Focus Entity File Number Entity File Number Current Fiscal Year End Date Current Fiscal Year End Date Entity Address, Address Line One Entity Address, Address Line One Entity Information, Former Legal or Registered Name Entity Filer Category Entity Filer Category Entity Current Reporting Status Entity Current Reporting Status Entity Tax Identification Number Entity Tax Identification Number Entity Emerging Growth Company Entity Emerging Growth Company Document Transition Report Document Transition Report Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Registrant Name Entity Registrant Name Pre-commencement Tender Offer Title of 12(b) Security Title of 12(b) Security Entity Address, State or Province Entity Address, State or Province Document Type Document Type Entity Shell Company Entity Shell Company Written Communications Security Exchange Name Security Exchange Name Entity Address, Address Line Two Entity Address, Address Line Two Entity Central Index Key Entity Central Index Key Entity Interactive Data Current Entity Interactive Data Current Local Phone Number Local Phone Number Pre-commencement Issuer Tender Offer Document Fiscal Year Focus Document Fiscal Year Focus Cover [Abstract] Trading Symbol Trading Symbol EX-101.SCH 4 omic-20230525.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document and Entity Information
May 25, 2023
Cover [Abstract]  
Entity Registrant Name Singular Genomics Systems, Inc.
Entity Central Index Key 0001850906
Document Type 8-K
Entity Information, Former Legal or Registered Name N/A
Document Period End Date May 25, 2023
Amendment Flag false
Entity Emerging Growth Company true
Entity Ex Transition Period false
Trading Symbol OMIC
Entity File Number 001-40443
Entity Tax Identification Number 81-2948451
Entity Address, Address Line One 3010 Science Park Road
Entity Address, City or Town San Diego
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92121
City Area Code 858
Local Phone Number 333-7830
Written Communications false
Soliciting Material false
Pre-commencement Issuer Tender Offer false
Pre-commencement Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001 per share
Security Exchange Name NASDAQ
Entity Incorporation, State or Country Code DE
XML 6 omic-20230525_htm.xml IDEA: XBRL DOCUMENT 0001850906 2023-05-25 2023-05-25 false 0001850906 8-K 2023-05-25 Singular Genomics Systems, Inc. DE 001-40443 81-2948451 3010 Science Park Road San Diego CA 92121 858 333-7830 N/A false false false false Common Stock, par value $0.0001 per share OMIC NASDAQ true false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 24 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports omic-20230525.htm omic-20230525.xsd omic-20230525_lab.xml omic-20230525_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "omic-20230525.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 24 }, "contextCount": 1, "dts": { "inline": { "local": [ "omic-20230525.htm" ] }, "labelLink": { "local": [ "omic-20230525_lab.xml" ] }, "presentationLink": { "local": [ "omic-20230525_pre.xml" ] }, "schema": { "local": [ "omic-20230525.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 37, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 0, "nsprefix": "omic", "nsuri": "http://singulargenomics.com/20230525", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "omic-20230525.htm", "contextRef": "C_9a8e8809-d470-4678-90c6-7e02b7129864", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "omic-20230525.htm", "contextRef": "C_9a8e8809-d470-4678-90c6-7e02b7129864", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationFormerLegalOrRegisteredName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Former Legal or Registered Name of an entity", "label": "Entity Information, Former Legal or Registered Name" } } }, "localname": "EntityInformationFormerLegalOrRegisteredName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230525/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 13 0000950170-23-024313-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-23-024313-xbrl.zip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end